456 related articles for article (PubMed ID: 21478260)
21. Effects of antidiabetic treatment with metformin and insulin on serum and adipose tissue adiponectin levels in db/db mice.
Fujita H; Fujishima H; Koshimura J; Hosoba M; Yoshioka N; Shimotomai T; Morii T; Narita T; Kakei M; Ito S
Endocr J; 2005 Aug; 52(4):427-33. PubMed ID: 16127210
[TBL] [Abstract][Full Text] [Related]
22. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
[TBL] [Abstract][Full Text] [Related]
23. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.
Neuhofer A; Zeyda M; Mascher D; Itariu BK; Murano I; Leitner L; Hochbrugger EE; Fraisl P; Cinti S; Serhan CN; Stulnig TM
Diabetes; 2013 Jun; 62(6):1945-56. PubMed ID: 23349501
[TBL] [Abstract][Full Text] [Related]
24. EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.
Prada PO; Ropelle ER; Mourão RH; de Souza CT; Pauli JR; Cintra DE; Schenka A; Rocco SA; Rittner R; Franchini KG; Vassallo J; Velloso LA; Carvalheira JB; Saad MJ
Diabetes; 2009 Dec; 58(12):2910-9. PubMed ID: 19696185
[TBL] [Abstract][Full Text] [Related]
25. β-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKβ/NF-κB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.
Jayaraman S; Devarajan N; Rajagopal P; Babu S; Ganesan SK; Veeraraghavan VP; Palanisamy CP; Cui B; Periyasamy V; Chandrasekar K
Molecules; 2021 Apr; 26(7):. PubMed ID: 33917607
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.
Mihara M; Aihara K; Ikeda Y; Yoshida S; Kinouchi M; Kurahashi K; Fujinaka Y; Akaike M; Matsumoto T
Endocrinology; 2010 Feb; 151(2):513-9. PubMed ID: 19966184
[TBL] [Abstract][Full Text] [Related]
27. Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages.
Miranville A; Herling AW; Biemer-Daub G; Voss MD
Obesity (Silver Spring); 2010 Dec; 18(12):2247-54. PubMed ID: 20379144
[TBL] [Abstract][Full Text] [Related]
28. Proresolution therapy for the treatment of delayed healing of diabetic wounds.
Tang Y; Zhang MJ; Hellmann J; Kosuri M; Bhatnagar A; Spite M
Diabetes; 2013 Feb; 62(2):618-27. PubMed ID: 23043160
[TBL] [Abstract][Full Text] [Related]
29. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis.
Rius B; Titos E; Morán-Salvador E; López-Vicario C; García-Alonso V; González-Périz A; Arroyo V; Clària J
FASEB J; 2014 Feb; 28(2):836-48. PubMed ID: 24249635
[TBL] [Abstract][Full Text] [Related]
30. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes.
van Diepen JA; Robben JH; Hooiveld GJ; Carmone C; Alsady M; Boutens L; Bekkenkamp-Grovenstein M; Hijmans A; Engelke UFH; Wevers RA; Netea MG; Tack CJ; Stienstra R; Deen PMT
Diabetologia; 2017 Jul; 60(7):1304-1313. PubMed ID: 28382382
[TBL] [Abstract][Full Text] [Related]
31. CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice.
Kang YS; Lee MH; Song HK; Ko GJ; Kwon OS; Lim TK; Kim SH; Han SY; Han KH; Lee JE; Han JY; Kim HK; Cha DR
Kidney Int; 2010 Nov; 78(9):883-94. PubMed ID: 20686445
[TBL] [Abstract][Full Text] [Related]
32. Improved insulin sensitivity in obese-diabetic mice via chitosan Nanomicelles mediated silencing of pro-inflammatory Adipocytokines.
Sharma D; Arora S; Banerjee A; Singh J
Nanomedicine; 2021 Apr; 33():102357. PubMed ID: 33460779
[TBL] [Abstract][Full Text] [Related]
33. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway.
Bao S; Wu YL; Wang X; Han S; Cho S; Ao W; Nan JX
J Ethnopharmacol; 2020 Jul; 257():112863. PubMed ID: 32302715
[TBL] [Abstract][Full Text] [Related]
34. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
Kang JW; Lee SM
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
[TBL] [Abstract][Full Text] [Related]
35. Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: implications for insulin resistance.
Zhang H; Chen X; Aravindakshan J; Sairam MR
Endocrinology; 2007 Dec; 148(12):5667-79. PubMed ID: 17717050
[TBL] [Abstract][Full Text] [Related]
36. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.
Fredman G; Ozcan L; Spolitu S; Hellmann J; Spite M; Backs J; Tabas I
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14530-5. PubMed ID: 25246560
[TBL] [Abstract][Full Text] [Related]
37. Cilostazol ameliorates systemic insulin resistance in diabetic db/db mice by suppressing chronic inflammation in adipose tissue via modulation of both adipocyte and macrophage functions.
Wada T; Onogi Y; Kimura Y; Nakano T; Fusanobori H; Ishii Y; Sasahara M; Tsuneki H; Sasaoka T
Eur J Pharmacol; 2013 May; 707(1-3):120-9. PubMed ID: 23528355
[TBL] [Abstract][Full Text] [Related]
38. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis.
Lee HN; Surh YJ
Biochem Pharmacol; 2013 Sep; 86(6):759-69. PubMed ID: 23856291
[TBL] [Abstract][Full Text] [Related]
39. Insulin sensitization via partial agonism of PPARγ and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats.
Gandhi GR; Stalin A; Balakrishna K; Ignacimuthu S; Paulraj MG; Vishal R
Biochim Biophys Acta; 2013 Jan; 1830(1):2243-55. PubMed ID: 23104384
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice.
Chapman J; Miles PD; Ofrecio JM; Neels JG; Yu JG; Resnik JL; Wilkes J; Talukdar S; Thapar D; Johnson K; Sears DD
PLoS One; 2010 Nov; 5(11):e13959. PubMed ID: 21103061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
